ETFChannel.com
SKBI Description — Skystar Bio-Pharmaceutical Co

Skystar Bio-Pharmaceutical, through its subsidiaries in the People's Republic of China (PRC) and Xi'an Tianxing Bio-Pharmaceutical Co., Limited (Xi'an Tianxing), is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products. Xi'an Tianxing and Co.'s subsidiary, Skystar Biotechnology (Jingzhou) Co., Limited primarily manufacture and distribute of veterinary drugs. Co. has four product lines: micro-organism, which includes 16 products; veterinary medicine for poultry and livestock, which includes 145 products; feed additives, which includes 16 products; and bio-pharmaceutical veterinary vaccine, which includes 10 products.

Company Name: 
Skystar Bio-Pharmaceutical Co
Website: 
www.skystarbio-pharmaceutical.com
Sector: 
Drugs & Pharmaceuticals
Quotes delayed 20 minutes

Email EnvelopeFree SKBI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (4.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding SKBI | Skystar Bio-Pharmaceutical Co | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2024, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.